Research / NVT / Fundamental state Inspectable configuration
State dimensions Filing 0001720635-22-000009 General Corporate
Debt relative to revenue 0th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.debt_to_revenue
40.58% · OPTIONAL · VALID
Capex intensity 40th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.60% · OPTIONAL · VALID
Operating cash generation 40th Own-history percentile · N=15
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
15.16% · OPTIONAL · VALID
Share-count growth 55th Own-history percentile · N=11
Evidence method Yoy · gp.fundamentals.shares_outstanding
-1.25% · CORE · VALID
Revenue growth 82th Own-history percentile · N=11
Evidence method Yoy · gp.fundamentals.revenue
23.19% · CORE · VALID
Inventory pressure 20th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
13.07% · OPTIONAL · VALID
Gross margin 27th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.gross_margin
38.26% · CORE · VALID
Operating margin 53th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.operating_margin
14.44% · CORE · VALID
R&D intensity 7th Own-history percentile · N=15
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.97% · OPTIONAL · VALID
SBC intensity 33th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.67% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Sep 30, 2021 10/10 normalized Level 3 Dec 31, 2021 10/10 normalized Level 3 Mar 31, 2022 10/10 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 10/10 normalized Level 3 Mar 31, 2023 10/10 normalized Level 3 Jun 30, 2023 10/10 normalized Level 3 Sep 30, 2023 10/10 normalized Level 3 Dec 31, 2023 10/10 normalized Level 3 Mar 31, 2024 10/10 normalized Level 3 Jun 30, 2024 10/10 normalized Level 3 Sep 30, 2024 10/10 normalized Level 3 Dec 31, 2024 10/10 normalized Level 3 Mar 31, 2025 10/10 normalized Level 3 Jun 30, 2025 10/10 normalized Level 3 Sep 30, 2025 10/10 normalized Level 3 Dec 31, 2025 10/10 normalized Level 3 Mar 31, 2026 10/10 normalized Level 3 Jun 30, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 151.14%
Current 40.58%
Delta -110.55% Capex Intensity Increased
Previous 1.14%
Current 1.60%
Delta 0.47% Cash Generation Decreased
Previous 17.86%
Current 15.16%
Delta -2.70% Dilution Decreased
Previous -1.11%
Current -1.25%
Delta -0.15% Growth Decreased
Previous 26.21%
Current 23.19%
Delta -3.03% Inventory Pressure Decreased
Previous 46.89%
Current 13.07%
Delta -33.81% Margin Decreased
Previous 38.97%
Current 38.26%
Delta -0.71% Profitability Decreased
Previous 15.20%
Current 14.44%
Delta -0.76% R And D Intensity Decreased
Previous 2.04%
Current 1.97%
Delta -0.06% Sbc Intensity Decreased
Previous 0.81%
Current 0.67%
Delta -0.13% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.